Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Deferred Taxes (2019 - 2025)

Historic Deferred Taxes for Sanofi (SNY) over the last 6 years, with Q4 2025 value amounting to -$2.8 billion.

  • Sanofi's Deferred Taxes fell 23130.87% to -$2.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.0 billion, marking a year-over-year decrease of 12682.39%. This contributed to the annual value of -$2.8 billion for FY2025, which is 21753.54% down from last year.
  • According to the latest figures from Q4 2025, Sanofi's Deferred Taxes is -$2.8 billion, which was down 23130.87% from -$857.0 million recorded in Q4 2024.
  • Sanofi's Deferred Taxes' 5-year high stood at -$19.6 million during Q4 2021, with a 5-year trough of -$2.8 billion in Q4 2025.
  • In the last 4 years, Sanofi's Deferred Taxes had a median value of -$1.1 billion in 2023 and averaged -$1.3 billion.
  • In the last 5 years, Sanofi's Deferred Taxes soared by 3539.94% in 2024 and then plummeted by 23130.87% in 2025.
  • Quarter analysis of 4 years shows Sanofi's Deferred Taxes stood at -$19.6 million in 2021, then crashed by 6681.72% to -$1.3 billion in 2023, then surged by 35.4% to -$857.0 million in 2024, then crashed by 231.31% to -$2.8 billion in 2025.
  • Its last three reported values are -$2.8 billion in Q4 2025, -$857.0 million for Q4 2024, and -$1.3 billion during Q4 2023.